Fired by the 'captain of industry'No doubt, you, dear reader, have experienced the unpleasant situation of terminating an employee for one reason or another (poor performance, financial exigencies, etc.). But I would hope that we ophthalmologists perform this task in a more professional manner than that exemplified by The Captain of Industry.
In this issue
Uncovering diagnostic clues, insights in pediatric neurodegenerative cases June 01, 2017By Lynda ChartersRecognition of the neuro-ophthalmic findings in pediatric neurodegenerative diseases may yield insight into the diagnosis of these diseases. Ophthalmic clues should not be overlooked. Patching after unilateral cataract: Less may be more June 01, 2017By Lynda ChartersGradual reductions in the amount of patching from 3 to 4 hours at 1 year of age showed significantly better outcomes in children who undergo unilateral congenital cataract surgery. Novel glaucoma treatments factor in scleral behavior June 01, 2017By Lynda ChartersInnovations in sustained-drug delivery and neuroprotection are bringing glaucoma specialists one step closer to additional therapeutic options. Study sheds light on in-room time with patients, EHR documentation June 01, 2017By Steve LenierThe implementation of electronic health records has had great impact on the way ophthalmologists spend their time. There are concerns that this has created inefficiencies, and that physicians now spend more time documenting, and less time with their patients, which is the opposite of what was intended. Intrastromal procedure favored for myopic treatmentA review of 800 cases of small incision lenticule extraction for treatment of myopia and myopic astigmatism shows an evolution in surgical indications and technique with consistently positive outcomes. Surveying old, new diagnostic tests for pediatric neuro-ophthalmic cases June 01, 2017By Vanessa CaceresNeuro-ophthalmology tests for children have made strides in the past 25 years, especially in the area of diagnostic technology. Though some testing devices remain useful, there are also advances such as in genetic testing that are being used with greater frequency. Sometimes the answer may simply be a ‘stem failure'There is nothing you can do to help a person modify his or her behavior, or to modify a clinic behavior, if the person simply does not see—or will not acknowledge—this behavior within himself or herself. KeraLink poised for new era in corneal transplantation June 01, 2017By Nancy GrovesAs part of a transformation to one of the pioneering eye banks in the country, Tissue Banks International (TBI) recently underwent a formal rebranding, changing its name to KeraLink International. This move included shedding the musculoskeletal portion of operations to concentrate on dramatically increasing the number of sight-saving procedures performed globally, explained Douglas Furlong, KeraLink’s president and chief executive officer.